qiaqiafeng
5 years ago
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced that company management will present at BTIGβs Virtual Biotechnology Conference on Monday August 10, 2020 at 11 a.m. EDT.
A live webcast of this presentation will be available under βEvents, Webcasts and Presentationsβ in the investors section of the IMV website and a replay will be available approximately one hour after the presentation. Afterwards, it will be available for approximately 30 days.
Bullish